Differential prognosis of patients that are candidates for standard, short or prolonged dual antiplatelet treatment discharged after an acute coronary syndrome
Thrombosis Research · 2023
DOI: 10.1016/j.thromres.2023.02.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis Research, 2023. Verfasst von Alberto Cordero und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department. Hospital Universitario de San Juan, Alicante, Spain; Unidad de Investigación de Cardiología, Fundación para el Fomento de la I…. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares.
Abstract (Originalsprache)
BACKGROUND: Current evidence supports the efficacy of prolonged dual antiplatelet treatment (DAPT) for patients at high-ischemic risk and low bleeding risk as well as the efficacy and safety of short DAPT in high-bleeding risk (HBR) patients. METHODS: We evaluated patterns of DAPT candidates in all patients discharged in 2 hospitals after an acute coronary syndrome (ACS). Patients categorized in 3 groups: 1) short-DAPT candidates if they met 1 major o 2 minor criteria for HBR, by the 2019 ARC-HBR criteria; 2) prolonged-DAPT candidates if were not HBR and had recurrent ACS, complex percutaneous coronary interventions or diabetes; 3) standard 12 months DAPT if were not include in the previous 2 groups. Major bleeding (MB) was registered according to 3 or 5 of the BARC consortium definitions. RESULTS: We included 8252 patients and 3215 (39 %) were candidates for abbreviated DAPT, 3119 (37.8 %) for prolonged DAPT, and 1918 (23.2 %) for 12 m DAPT. Relevant differences were observed between the 3 categories beyond the bleeding risk. Median follow-up was 57 months. Multivariate analysis identified higher risk of all-cause mortality (HR: 1.96 95 % CI 1.45-2.67; p < 0.001), cardiovascular mortality (HR: 2.10 95 % CI 1.39-3.19; p < 0.011), MACE (HR: 1.69 95 % 1.50-2.02; p < 0.001) and MB (sHR: 3.41 95 % CI 1.45-8.02; p = 0.005) in candidates to short DAPT. Candidates to prolonged DAPT had higher risk of MACE (HR: 1.17 95 % CI 1.02-1.35; p = 0.027). CONCLUSIONS: Almost two thirds of patients discharged after an ACS would be candidates for short or prolonged DAPT and these patients are at higher risk of MACE and mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiology Department. Hospital Universitario de San Juan, Alicante, Spain; Unidad de Investigación de Cardiología, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO…
- Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain; Cardiology Department, Complejo Hospital Universitario de Santiago, Santiago de Compostela, Spain.
Förderung
- Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares
Zitieren
APA
Cordero, A., Escribano, D., García-Acuña, J. M., Alvarez-Alvarez, B., Cid-Alvarez, B., Rodriguez-Mañero, M., Agra-Bermejo, R., Quintanilla, M. A., Zuazola, P., & González-Juanatey, J. R. (2023). Differential prognosis of patients that are candidates for standard, short or prolonged dual antiplatelet treatment discharged after an acute coronary syndrome. Thrombosis Research. https://doi.org/10.1016/j.thromres.2023.02.008
Vancouver
Cordero A, Escribano D, García-Acuña JM, Alvarez-Alvarez B, Cid-Alvarez B, Rodriguez-Mañero M, et al. Differential prognosis of patients that are candidates for standard, short or prolonged dual antiplatelet treatment discharged after an acute coronary syndrome. Thrombosis Research. 2023. doi:10.1016/j.thromres.2023.02.008
BibTeX
@article{Cordero2023,
author = {Cordero, Alberto and Escribano, David and García-Acuña, José Mª and Alvarez-Alvarez, Belén and Cid-Alvarez, Belén and Rodriguez-Mañero, Moisés and Agra-Bermejo, Rosa and Quintanilla, Mª Amparo and Zuazola, Pilar and González-Juanatey, José R},
title = {Differential prognosis of patients that are candidates for standard, short or prolonged dual antiplatelet treatment discharged after an acute coronary syndrome},
journal = {Thrombosis Research},
year = {2023},
doi = {10.1016/j.thromres.2023.02.008}
}
EUVIMED